Number of Shares
-
Current Holdings Value*
N/A
% of Portfolio
0%
Total Estimate Gain
円12.85 Mil
% of Total Estimate Gain
51.31%

DWS ESG International Core Equity Fund's Chugai Pharmaceutical Co Ltd Holding Summary

As of 2025-02-28, DEUTSCHE DWS GLOBAL/INTERNATIONAL FUND, INC. held - shares of Chugai Pharmaceutical Co Ltd(TSE:4519), totaling N/A. This investment constitutes 0% of their stock portfolio, and DEUTSCHE DWS GLOBAL/INTERNATIONAL FUND, INC. now holds 0% of the outstanding Chugai Pharmaceutical Co Ltd(TSE:4519) stock.

The initial trade took place in 2019Q4. And since then DWS ESG International Core Equity Fund has made 5 purchases of TSE:4519, at an average price of 円3,478.74, for a total of 7,200.00 shares. In addition, there have been 7 sales at an average price of 円5,263.85 for 7,200.00 shares. Based on historical transaction data and TSE:4519's current price of 円7004.00, DWS ESG International Core Equity Fund's estimated gain on his TSE:4519 holdings is 円12.85 Mil, reflecting a 51.31% gain to date.

DWS ESG International Core Equity Fund TSE:4519 (円7004.00) Holding Chart

DWS ESG International Core Equity Fund TSE:4519 (円7004.00) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price 円-/Share
Shares Sold 0 Average Price 円-/Share
Current Price 円0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1